ACS publishes revised colorectal cancer screening guidelines

The American Cancer Society (ACS) announced revisions to their colorectal cancer screening guidelines. The organization hopes this action will lead to increased screening rates nationwide.

The new guidelines include additional screening options for eligible adults. Key updates:

• Multitarget stool tests Cologuard and ColoSense have been added as screening options.
• Blood tests that detect tumor DNA in the blood have also been added as screening options.
• The “Shield” blood test can be used by patients “who decline or do not complete preferred screening tests.”
• The ACS suggests that anyone who uses the blood or stool options to test for colorectal cancer should undergo a follow-up colonoscopy before six months.

The recommended screening age is still 45-75 for those with average disease risk, with a cutoff at age 85. Previous at-home and in-person tests are still included in the new guideline. ACS officials emphasize that screened is best. Chief Scientific Officer Dr. William Dahut said, “No matter which test you choose, what’s most important is to get screened, and that includes underserved, rural, and minority populations. These changes were developed to add to the colorectal cancer screening arsenal and help ensure preventive cancer care is available to all.”